HIV-gag codon-optimised DNA vaccines

Details for Australian Patent Application No. 2002362368 (hide)

Owner Glaxo Group Limited

Inventors Beaton, Andrew; Van Wely, Catherine Ann; Lear, Andrew; Gough, Gerald Wayne; Ertl, Peter Franz; Tite, John Philip

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002362368

PCT Number PCT/EP02/10592

PCT Pub. Number WO2003/025003

Priority 0129604.5 11.12.01 GB; PCT/GB01/04207 20.09.01 GB; 0206462.4 19.03.02 GB

Filing date 18 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 21 September 2006

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 May 2003 Complete Application Filed

  Priority application(s): 0129604.5 11.12.01 GB; PCT/GB01/04207 20.09.01 GB; 0206462.4 19.03.02 GB

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002362368

21 September 2006 Application Accepted

  Published as AU-B-2002362368

18 January 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002362369-DISPENSING CLOSURE FOR A CONTAINER THAT HOLDS POURABLE MATERIAL

2002362367-HERBICIDAL COMPOSITION